Everyone working in the pharmaceutical industry is very aware of the need for improved productivity. The cost of R&D continues to grow rapidly while the number of new drugs being brought to the market has dwindled which has led to the recent significant reductions in the in-house research efforts in large pharmaceutical companies.
This established symposium will highlight recent advances in technology-enabled drug discovery as well as new synthetic technologies with particular relevance to medicinal chemistry.This will be the eighth meeting in this series.
This established symposium will highlight recent advances in technology-enabled drug discovery as well as new synthetic technologies with particular relevance to medicinal chemistry.This will be the eighth meeting in this series.
